换帅撤指引后再添困境 联合健康(UNH.US)证实面临美司法部医保调查

智通财经网
Jul 24, 2025

智通财经APP获悉,联合健康集团(UNH.US)周四在文件中表示,公司正响应美国司法部(DOJ)有关其医保(Medicare)业务操作的刑事及民事调查请求,证实了过去两年间不断传出的调查传闻。该公司称正积极配合调查,并强调“长期以来秉持负责任的经营理念,合规记录良好”。 此次调查确认,让这家医疗健康巨头的困境再添一笔,公司近期已更换高管,并撤回了业绩指引。

截至发稿,周四纽约盘前交易中,联合健康股价下跌逾3%。

近年来,联合健康多次成为司法部调查对象:2024年,一项反垄断调查曝光;今年5月,《华尔街日报》报道称,调查人员至少自去年夏天起就已在核查其医保优势计划(Medicare Advantage)业务。

“我们坚信医保优势计划的运营诚信可靠,”联合健康在官网声明中回应相关报道时表示。

多年来,保险公司的医保优势计划操作一直备受质疑。在该计划中,保险公司为病情较重的患者提供服务可获得更高报酬,而报酬水平由其申报的诊断代码决定。监管机构及举报人指控,部分公司通过夸大患者病情来抬高利润,已有多家企业为此支付巨额赔偿金以了结相关案件。

更多港股重磅资讯,下载智通财经app

更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10